Oral Helicobacter Pylori Eradication

Status Recruiting

Clinical Trial Summary

Helicobacter pylori (H. pylori) is a serious health threat that infects approximately half of the global population. In addition to colonizing the stomach, H. pylori has been shown to survive in the oral microenvironment and is associated with a variety of oral diseases, gastric eradication failure, and reinfection. Currently, traditional systemic antibiotic therapy has little effect on oral H. pylori, and mouthwashes available on the market for oral H. pylori eradication often contain multiple antibiotics or complex essential ingredients, which can cause unpredictable effects on the human body. Therefore, there is an urgent need for a mouthwash that does not contain antibiotics and is effective against oral H. pylori. This study focuses on the eradication effect of MAXPOWER Biological Antibacterial mouthwash on oral H. pylori in a population.

Clinical Trial Description

Inclusion criteria: oral H. pylori-positive patients, verified by H. pylori saliva test (HPS),aged 18-70 years visiting the outpatient clinic of Changhai Hospital from March 1, 2023, to August 1, 2023, were enrolled. Exclusion criteria: (1) Zollinger-Ellison syndrome, gastric cancer, upper gastrointestinal bleeding, or active peptic ulcer; (2) the coexistence of significant concomitant illnesses, including heart diseases, renal failure, hepatic disease, previous abdominal surgery, lactation or pregnancy; and (3) not willing to participate in the study. Written informed consent was obtained from all patients prior to participation in the study. ;

Study Design

Related Conditions & MeSH terms

H. Pylori Infection

Clinical Trial Details

NCT number	NCT06045832
Study type	Interventional
Source	Changhai Hospital
Contact	Yongkang Lai, Dr.
Phone	+86-18270881495
Email	4090275844@qq.com
Status	Recruiting
Phase	N/A
Start date	March 1, 2023
Completion date	September 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06045494` - The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21	N/A
Not yet recruiting	`NCT01449500` - Supplementation With L. Reuteri in H. Pylori Infected Adults	N/A
Completed	`NCT01234389` - Immediate Detection of Helicobacter Infection With a New Electrochemical System.	N/A
Not yet recruiting	`NCT05387005` - Screening Strategy for Gastric Cancer Prevention	N/A
Not yet recruiting	`NCT02761005` - Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori	Phase 2
Recruiting	`NCT03142620` - Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study	Phase 3
Withdrawn	`NCT02090738` - A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide	Phase 2
Recruiting	`NCT01335334` - H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study	Phase 4
Recruiting	`NCT05544396` - Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.	N/A
Recruiting	`NCT04713670` - Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection	Phase 4
Completed	`NCT05453994` - Bismuth for PCAB-based H. Pylori Eradication
Recruiting	`NCT02328131` - European Registry on the Management of Helicobacter Pylori Infection
Completed	`NCT00197457` - Pepsinogens as the Early Marker of H. Pylori Eradication	Phase 2
Completed	`NCT04036838` - ARJ C13 Urea Breath Test System	Phase 2
Completed	`NCT06050824` - A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection	Phase 4
Completed	`NCT02767479` - Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori	Phase 3
Completed	`NCT01505127` - Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori	Phase 3
Recruiting	`NCT05176821` - Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection	N/A
Completed	`NCT05002595` - H. Pylori Treatment Between Modified Quadruple Regimen and Tailored Therapy
Recruiting	`NCT03597672` - Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01)